Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019

SELL
$31.84 - $50.88 $413,920 - $661,440
-13,000 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$42.0 - $59.29 $546,000 - $770,770
13,000 New
13,000 $668,000
Q1 2019

May 14, 2019

SELL
$40.82 - $62.45 $449,020 - $686,950
-11,000 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$65.0 - $82.15 $715,000 - $903,650
11,000 New
11,000 $831,000

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $429M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Employees Retirement System Of Texas Portfolio

Follow Employees Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Employees Retirement System Of Texas with notifications on news.